High Evidence (L1-L2)
Candidates that may be prioritised for clinical evaluation
Criteria
| Level | Definition | Clinical meaning |
|---|---|---|
| L1 | Multiple Phase 3 RCTs / systematic reviews | Strong support; clinical use may be considered |
| L2 | Single RCT or multiple Phase 2 trials | Moderate support; validation trials can be designed |
L1 (52 drugs)
| Drug | Indications | Link |
|---|---|---|
| ALUMINUM HYDROXIDE | View report | |
| Aluminum Hydroxide | 4 | View report |
| Aripiprazole | 10 | View report |
| Atorvastatin | 6 | View report |
| Azathioprine | 10 | View report |
| Betamethasone | 10 | View report |
| Bleomycin | 6 | View report |
| Capecitabine | 10 | View report |
| Carboplatin | 10 | View report |
| Celecoxib | 10 | View report |
| Chloramphenicol | 9 | View report |
| Clonidine | 10 | View report |
| Clotrimazole | 3 | View report |
| Cyclophosphamide | 5 | View report |
| Dantrolene | 9 | View report |
| Dapsone | 1 | View report |
| Doxorubicin | 10 | View report |
| Epinephrine | 4 | View report |
| Flunarizine | 1 | View report |
| Flutamide | 10 | View report |
| Goserelin | 3 | View report |
| Hydroxyzine | 5 | View report |
| Ifosfamide | 10 | View report |
| Imiquimod | 10 | View report |
| Ipratropium | 10 | View report |
| Ketamine | 1 | View report |
| Ketorolac | 3 | View report |
| Letrozole | 10 | View report |
| Lidocaine | 10 | View report |
| Medroxyprogesterone Acetate | 10 | View report |
| Neostigmine | 10 | View report |
| Nepafenac | 10 | View report |
| Oxymetazoline | 3 | View report |
| Paclitaxel | 10 | View report |
| Pantoprazole | 6 | View report |
| Potassium | 5 | View report |
| Ranitidine | 10 | View report |
| Rifabutin | 10 | View report |
| Rifapentine | 10 | View report |
| Rilpivirine | 5 | View report |
| Risperidone | 6 | View report |
| Salmeterol | 7 | View report |
| Simvastatin | 8 | View report |
| Spectinomycin | 10 | View report |
| Streptokinase | 10 | View report |
| Tacrolimus | 3 | View report |
| Tegafur | 10 | View report |
| Terbutaline | 3 | View report |
| Tiotropium | 10 | View report |
| Tolvaptan | 10 | View report |
| Trastuzumab | 10 | View report |
| Zolpidem | 3 | View report |
L2 (46 drugs)
| Drug | Indications | Link |
|---|---|---|
| Acetazolamide | 10 | View report |
| Acetylcysteine | 10 | View report |
| Ascorbic Acid | 10 | View report |
| Aztreonam | 10 | View report |
| Calcitriol | 7 | View report |
| Ceftazidime | 10 | View report |
| Ceftriaxone | 7 | View report |
| Cetirizine | 6 | View report |
| Clozapine | 10 | View report |
| Danazol | 10 | View report |
| Dexamethasone | 10 | View report |
| Diazepam | 10 | View report |
| Diclofenac | 10 | View report |
| Dorzolamide | 10 | View report |
| Everolimus | 10 | View report |
| Hydrocortisone | 10 | View report |
| Irinotecan | 1 | View report |
| Isosorbide Dinitrate | 10 | View report |
| Lamotrigine | 9 | View report |
| Latanoprost | 10 | View report |
| Mefenamic Acid | 8 | View report |
| Megestrol Acetate | 10 | View report |
| Melphalan | 10 | View report |
| Mercaptopurine | 10 | View report |
| Methylphenidate | 4 | View report |
| Midazolam | 1 | View report |
| Mitoxantrone | 8 | View report |
| Montelukast | 5 | View report |
| Morphine | 10 | View report |
| Mycophenolate Mofetil | 10 | View report |
| Mycophenolic Acid | 10 | View report |
| Nitroglycerin | 5 | View report |
| Nystatin | 10 | View report |
| Oxaliplatin | 4 | View report |
| Phenylephrine | 3 | View report |
| Phenytoin | 10 | View report |
| Prednisolone | 10 | View report |
| Prednisone | 10 | View report |
| Propofol | 5 | View report |
| Pyridostigmine | 7 | View report |
| Selegiline | 4 | View report |
| Sirolimus | 10 | View report |
| Sucralfate | 2 | View report |
| Topiramate | 9 | View report |
| Trimethoprim | 2 | View report |
| Vincristine | 3 | View report |
Disclaimer
This report is for academic research reference only and does not constitute medical advice. Always follow your physician's instructions; never adjust medication on your own. Any drug repurposing decision requires full clinical validation and regulatory review.
Reviewed by: 藥提醒科技有限公司 (yao.care)
This report is for academic research reference only and does not constitute medical advice. Always follow your physician's instructions; never adjust medication on your own. Any drug repurposing decision requires full clinical validation and regulatory review.
Reviewed by: 藥提醒科技有限公司 (yao.care)